Ritalin LA once-daily extended release methylphenidate capsules regulatory update

The FDA granted marketing approval for NVS's Ritalin LA to treat attention deficit hyperactivity disorder (ADHD). The once-daily formulation uses SODAS (spheroidal oral drug delivery system) technolog...